OBJECTIVE: We wished to explore short-term efficacy of surgical treatment of @entity3528 in @entity1 with the @entity454 . The treatment methods were subtotal or total parathyroidectomy, or total parathyroidectomy and autotransplantation. @entity1 AND METHODS: 63 @entity1 with @entity3528 were randomly divided into three groups which were respectively treated with @entity512 (SPTX group), total parathyroidectomy (TPTX group), or total parathyroidectomy and autotransplantation (TPTX+AT group). The surgical outcomes included operating time, transoperative @entity548 volume, length of stay, and cost of hospitalization. In addition, complication (e.g., postoperative wound @entity281 , @entity1410 , @entity3747 in perioperative period) rates were compared among groups. Blood levels of @entity460 and parathyroid hormone were assessed before the surgery, and 1 day, 1 months, 3 months and 6 months after the surgery. The follow-up period comprised 6 months. RESULTS: Surgical outcomes were the lowest in SPTX group and the highest in in TPTX+AT group. There were no significant differences among groups in treatment efficacy. Complication rates were also comparable among the three groups. The occurrence of @entity3747 was the lowest in SPTX group (p < 0.05 vs. other groups). However, postoperative relapse rate was the highest in this group (p < 0.05 vs. other groups). There were no correlations between the levels of blood @entity460 and @entity461 preoperatively and postoperatively. CONCLUSIONS: Appropriate surgical treatment is selected in accordance with the @entity1 's condition and willingness, with the attention paid to the prevention of @entity3747 .

Short-term efficacy of surgical treatment of XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'PATIENTS'] @entity3747 :: ('MESH:D006996', 'Disease') :: ['hypocalcemia'] @entity548 :: ('MESH:D006470', 'Disease') :: ['bleeding'] @entity3528 :: ('MESH:D006962', 'Disease') :: ['secondary hyperparathyroidism'] @entity281 :: ('MESH:D007239', 'Disease') :: ['infection'] @entity1410 :: ('MESH:D006406', 'Disease') :: ['hematoma'] @entity460 :: ('MESH:D002118', 'Chemical') :: ['calcium'] @entity512 :: ('MESH:C567308', 'Disease') :: ['subtotal parathyroidectomy'] @entity461 :: ('5741', 'Gene') :: ['PTH'] @entity454 :: ('MESH:D007676', 'Disease') :: ['end-stage renal disease']
@entity3528 :: (MESH:D006962,Disease) :: ['secondary hyperparathyroidism']
